KAT5 and neuroblastoma: As a result, both p300 inhibitor (CPI-637) and NAT10 inhibitor (Remodelin hydrobromide), but not KAT5 inhibitor (NU9056), reduced N-Myc protein expression in MYCN-amplified NB cells (Figs. 4, A–C and S1, C and F).